bioRxiv Science⌕ Search

Biology subjects

Weke, K.

Publications and source records attributed to Weke, K..

3 recordsLinked to original sources

Informatics Methods to Enhance Bacterial Peptide Detection

Detecting low-abundance bacterial peptides in samples dominated by human proteins using liquid chromatography tandem mass spectrometry (LC MS/MS) is challenging. Bacterial peptides are typically far less abundant than host-derived peptides, and sequence similarity between bacterial and human peptides can complicate confident attribution to a bacterial origin. To address this problem, we developed and benchmarked an in silico spectral library protein identification workflow for detecting Staphylococcus aureus USA300 peptides against a background of A375 cells. Peptide and protein identifications obtained at a 1% peptide-level false discovery rate were compared between the in silico spectral library search and a conventional sequence database search across a defined bacterial dilution series containing 0, 1%, 2%, 10%, 25%, 50%, and 100% bacterial protein. A human sequence similarity filter was applied to identifications from both search strategies to reduce the likelihood of retaining human derived or human like peptide sequences. Both search strategies showed concentration dependent bacterial detection and shared a practical detection limit of approximately 1 to 2% bacterial protein but exhibited distinct performance profiles. The in silico spectral library search produced fewer bacterial-like background identifications in the human-only control, whereas MS2Rescore substantially increased spectral library identifications at higher bacterial concentrations, exceeding database search at 100% bacterial protein. The partially overlapping peptide sets identified by the two strategies indicate that they provide complementary coverage of the bacterial proteome.

biochemistry↗

Host adaptation drives genome evolution and virulence diversification in a bacterial zoonotic pathogen

Understanding how zoonotic pathogens diversify across reservoir hosts remains a central question in evolutionary biology and infectious disease research. Here, we address this challenge using Leptospira interrogans, a globally distributed bacterial pathogen with an extremely wide range of animal reservoirs, as a model. After defining 13 distinct genogroups that largely align with serogroups, we selected the strongly host-adapted rodent-associated lineage, which is more frequently associated with fatal outcomes in patients, and the cattle-associated lineage for further analysis. A comprehensive approach integrating multi-omics analyses and host-specific infection assays showed that these two genogroups have followed distinct evolutionary trajectories associated with host specialization. Genomics demonstrated that specialized genogroups are genetically less diverse, characterized by divergence in membrane and signaling genes, and by the acquisition of host-adaptive functions. Changes in gene expression and protein production revealed distinct regulatory programs, predominantly affecting virulence pathways in rodent-borne lineage and stress responses in cattle-borne lineage. Consistently, rodent-borne lineage causes greater disruption of human epithelial barrier integrity and elicits an attenuated host-dependent macrophage inflammatory response relative to cattle-borne lineage. Collectively, these findings reveal distinct host-adaptive strategies and remarkable evolutionary plasticity in a major zoonotic bacterium, highlighting the central role of intraspecies heterogeneity in shaping host specialization.

microbiology↗

A comprehensive library of canonical and non-canonical MHC class I antigens for cancer vaccine development.

A longstanding disconnect between the growing number of MHC Class I immunopeptidomic studies and genomic medicine hinders cancer vaccine design. We develop COD-dipp to genomically map the full spectrum of detected canonical and non-canonical (non-exonic) MHC Class I antigens from 26 cancer studies. We demonstrate that patient mutations in regions overlapping physically identified antigens better predict immunotherapy response when compared to neoantigen predictions. We suggest a vaccine design approach using 140,966 highly immune-visible regions of the genome annotated by their expression and haplotype frequency in the human population. These regions tend to be highly conserved, mutated in cancer and harbor 7.8 times more immunogenicity. Intersecting pan-cancer mutations with these immune surveilled regions revealed a potential to create off-the-shelf multi-epitope vaccines against public neoantigens. Here we release COD-dipp, a cancer vaccine toolkit as a web-application (https://www.proteogenomics.ca/COD-dipp) and open-source high-throughput resource.

bioinformatics↗